1078 related articles for article (PubMed ID: 32157661)
1. Metabolites Linking the Gut Microbiome with Risk for Type 2 Diabetes.
Zhu T; Goodarzi MO
Curr Nutr Rep; 2020 Jun; 9(2):83-93. PubMed ID: 32157661
[TBL] [Abstract][Full Text] [Related]
2. The Gut Microbial Endocrine Organ in Type 2 Diabetes.
Massey W; Brown JM
Endocrinology; 2021 Feb; 162(2):. PubMed ID: 33373432
[TBL] [Abstract][Full Text] [Related]
3. Gut-Microbial Metabolites, Probiotics and Their Roles in Type 2 Diabetes.
Zhai L; Wu J; Lam YY; Kwan HY; Bian ZX; Wong HLX
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884651
[TBL] [Abstract][Full Text] [Related]
4. Altered Gut Microbiota in Type 2 Diabetes: Just a Coincidence?
Sircana A; Framarin L; Leone N; Berrutti M; Castellino F; Parente R; De Michieli F; Paschetta E; Musso G
Curr Diab Rep; 2018 Sep; 18(10):98. PubMed ID: 30215149
[TBL] [Abstract][Full Text] [Related]
5. Gut microbiota-derived metabolites as central regulators in metabolic disorders.
Agus A; Clément K; Sokol H
Gut; 2021 Jun; 70(6):1174-1182. PubMed ID: 33272977
[TBL] [Abstract][Full Text] [Related]
6. The role of microbial amino acid metabolism in host metabolism.
Neis EP; Dejong CH; Rensen SS
Nutrients; 2015 Apr; 7(4):2930-46. PubMed ID: 25894657
[TBL] [Abstract][Full Text] [Related]
7. Modulating the Microbiota as a Therapeutic Intervention for Type 2 Diabetes.
Huda MN; Kim M; Bennett BJ
Front Endocrinol (Lausanne); 2021; 12():632335. PubMed ID: 33897618
[TBL] [Abstract][Full Text] [Related]
8. Gut Microbiota and Cardiovascular Disease.
Witkowski M; Weeks TL; Hazen SL
Circ Res; 2020 Jul; 127(4):553-570. PubMed ID: 32762536
[TBL] [Abstract][Full Text] [Related]
9. Gut microbiome and type 2 diabetes: where we are and where to go?
Sharma S; Tripathi P
J Nutr Biochem; 2019 Jan; 63():101-108. PubMed ID: 30366260
[TBL] [Abstract][Full Text] [Related]
10. Targeting the gut microbiota and its metabolites for type 2 diabetes mellitus.
Wu J; Yang K; Fan H; Wei M; Xiong Q
Front Endocrinol (Lausanne); 2023; 14():1114424. PubMed ID: 37229456
[TBL] [Abstract][Full Text] [Related]
11. Interaction between gut microbiome and cardiovascular disease.
Peng J; Xiao X; Hu M; Zhang X
Life Sci; 2018 Dec; 214():153-157. PubMed ID: 30385177
[TBL] [Abstract][Full Text] [Related]
12. The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus.
Kootte RS; Vrieze A; Holleman F; Dallinga-Thie GM; Zoetendal EG; de Vos WM; Groen AK; Hoekstra JB; Stroes ES; Nieuwdorp M
Diabetes Obes Metab; 2012 Feb; 14(2):112-20. PubMed ID: 21812894
[TBL] [Abstract][Full Text] [Related]
13. Diabetes and branched-chain amino acids: What is the link?
Bloomgarden Z
J Diabetes; 2018 May; 10(5):350-352. PubMed ID: 29369529
[TBL] [Abstract][Full Text] [Related]
14. Understanding connections and roles of gut microbiome in cardiovascular diseases.
Rajendiran E; Ramadass B; Ramprasath V
Can J Microbiol; 2021 Feb; 67(2):101-111. PubMed ID: 33079568
[TBL] [Abstract][Full Text] [Related]
15. The gut microbiota as a novel regulator of cardiovascular function and disease.
Battson ML; Lee DM; Weir TL; Gentile CL
J Nutr Biochem; 2018 Jun; 56():1-15. PubMed ID: 29427903
[TBL] [Abstract][Full Text] [Related]
16. The microbiome and its pharmacological targets: therapeutic avenues in cardiometabolic diseases.
Neves AL; Chilloux J; Sarafian MH; Rahim MB; Boulangé CL; Dumas ME
Curr Opin Pharmacol; 2015 Dec; 25():36-44. PubMed ID: 26531326
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive relationships between gut microbiome and faecal metabolome in individuals with type 2 diabetes and its complications.
Zhao L; Lou H; Peng Y; Chen S; Zhang Y; Li X
Endocrine; 2019 Dec; 66(3):526-537. PubMed ID: 31591683
[TBL] [Abstract][Full Text] [Related]
18. Gut microbiota-derived metabolites as key actors in inflammatory bowel disease.
Lavelle A; Sokol H
Nat Rev Gastroenterol Hepatol; 2020 Apr; 17(4):223-237. PubMed ID: 32076145
[TBL] [Abstract][Full Text] [Related]
19. Gut microbiota-derived metabolites as key actors in type 2 diabetes mellitus.
Du L; Li Q; Yi H; Kuang T; Tang Y; Fan G
Biomed Pharmacother; 2022 May; 149():112839. PubMed ID: 35325852
[TBL] [Abstract][Full Text] [Related]
20. Diet-induced metabolic changes of the human gut microbiome: importance of short-chain fatty acids, methylamines and indoles.
Abdul Rahim MBH; Chilloux J; Martinez-Gili L; Neves AL; Myridakis A; Gooderham N; Dumas ME
Acta Diabetol; 2019 May; 56(5):493-500. PubMed ID: 30903435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
